Published in Biomed Res Int on March 10, 2015
Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients | NCT00975000
Characteristics of Persistent Hyperparathyroidism After Renal Transplantation. World J Surg (2016) 0.75
Mineral and bone disorder after kidney transplantation. World J Transplant (2015) 0.75
A note on quantifying follow-up in studies of failure time. Control Clin Trials (1996) 7.96
Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med (2004) 6.52
KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant (2009) 6.43
Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study. J Am Soc Nephrol (2005) 2.91
Physiology and pathophysiology of the calcium-sensing receptor in the kidney. Am J Physiol Renal Physiol (2009) 2.02
KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis (2010) 1.93
Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest (1966) 1.81
Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease. Am J Physiol Renal Physiol (2010) 1.78
Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant (2004) 1.75
Early calcification of renal allografts detected by protocol biopsies: causes and clinical implications. Am J Transplant (2005) 1.54
Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. J Am Soc Nephrol (2003) 1.48
Posttransplant acidosis and associated disorders of mineral metabolism in patients with a renal graft. Transplantation (2007) 1.48
Management of hypercalcemia after renal transplantation. Nefrologia (2013) 1.44
The calcimimetic cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism. Nephrol Dial Transplant (2005) 1.44
Tertiary hyperparathyroidism in kidney transplant recipients: characteristics of patients selected for different treatment strategies. Transplantation (2012) 1.42
Cell biology of parathyroid gland hyperplasia in chronic renal failure. J Am Soc Nephrol (2000) 1.37
Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clin J Am Soc Nephrol (2006) 1.33
Parathyroidectomy after successful kidney transplantation: a single centre study. Nephrol Dial Transplant (2007) 1.31
Massive extraskeletal calcification during phosphate treatment of hypercalcemia. Arch Intern Med (1968) 1.27
An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. Clin Nephrol (2008) 1.22
Vitamin D status in renal transplant recipients. Am J Transplant (2007) 1.13
Caution in the use of phosphates in the treatment of severe hypercalcemia. J Clin Endocrinol Metab (1967) 1.13
Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transplant (2006) 1.11
Surgical treatment of persistent hyperparathyroidism after renal transplantation. Ann Surg (2008) 1.11
Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients. Nephrol Dial Transplant (2006) 1.06
Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials. PLoS Med (2013) 1.01
Elevated serum phosphate predicts mortality in renal transplant recipients. Transplantation (2009) 1.00
Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation. Am J Transplant (2013) 0.99
Bone disease after renal transplantation. Clin J Am Soc Nephrol (2006) 0.98
Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet. Am J Transplant (2006) 0.98
Hypercalcemia in renal transplant patients: prevalence and management in Canadian transplant practice. Clin Transplant (2013) 0.97
Progression of coronary artery calcification in renal transplantation and the role of secondary hyperparathyroidism and inflammation. Clin J Am Soc Nephrol (2009) 0.95
Reduced fracture risk with early corticosteroid withdrawal after kidney transplant. Am J Transplant (2011) 0.94
The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling. Kidney Int (2003) 0.93
Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Transplantation (2006) 0.92
Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation. Transplantation (2007) 0.91
Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation. Am J Transplant (2007) 0.91
Functional proteins involved in regulation of intracellular Ca(2+) for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics. J Pharmacol Sci (2005) 0.90
Cinacalcet-associated graft dysfunction and nephrocalcinosis in a kidney transplant recipient. Am J Med (2007) 0.89
Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism. Am J Kidney Dis (2008) 0.88
Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism. Transplantation (2008) 0.88
Cinacalcet for the treatment of hyperparathyroidism in kidney transplant recipients: a systematic review and meta-analysis. Transplantation (2012) 0.87
Histologic evolution of bone disease 6 months after successful kidney transplantation. Am J Kidney Dis (2004) 0.87
Hypercalciuria induced by a high dose of cinacalcet in a renal-transplant recipient. Clin Nephrol (2007) 0.87
Effects of cinacalcet in renal transplant patients with hyperparathyroidism. Am J Nephrol (2012) 0.86
Pharmacokinetics and pharmacodynamics of cinacalcet in patients with hyperparathyroidism after renal transplantation. Am J Transplant (2008) 0.86
Renal phosphate loss in long-term kidney transplantation. Clin J Am Soc Nephrol (2011) 0.85
Abnormal bone and mineral metabolism in kidney transplant patients--a review. Am J Nephrol (2007) 0.85
Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant (2007) 0.85
Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation. Transplantation (2008) 0.85
Impact of cinacalcet hydrochloride on bone histology in patients with secondary hyperparathyroidism. Ther Apher Dial (2008) 0.83
Cinacalcet decreases bone formation rate in hypercalcemic hyperparathyroidism after kidney transplantation. Am J Nephrol (2010) 0.83
Hyperparathyroidism and long-term bone loss after renal transplantation. Clin Transplant (2003) 0.82
Cinacalcet improves bone density in post-kidney transplant hyperparathyroidism. Transplant Proc (2010) 0.82
Renal allograft failure in a hyperparathyroid patient following initiation of a calcimimetic. Nat Rev Nephrol (2010) 0.82
Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation. Bone (2012) 0.81
Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up. Transplant Proc (2012) 0.81
The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism. Transplantation (2011) 0.81
Renal function in patients treated with cinacalcet for persistent hyperparathyroidism after kidney transplantation. Kidney Blood Press Res (2011) 0.80
Clinical impact of hypercalcemia in kidney transplant. Int J Nephrol (2011) 0.80
Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal. Transplant Proc (2012) 0.80
Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study. Nephrology (Carlton) (2014) 0.80
Cinacalcet lowers FGF-23 level together with bone metabolism in hemodialyzed patients with secondary hyperparathyroidism. Int Urol Nephrol (2011) 0.79
Treatment of hyperparathyroidism with cinacalcet in kidney transplant recipients. Transplant Proc (2010) 0.77
Hypercalcemia secondary to persistent hyperparathyroidism in kidney transplant patients: analysis after a year with cinacalcet. J Nephrol (2010) 0.77
Clinical manifestations of hypercalcemia and hypophosphatemia after kidney transplantation. Transplant Proc (2012) 0.77